Renal Stem Cell Biology Starts to Take Spherical Shape Commentary on: Lusis et al., Isolation of clonogenic, long-term self renewing embryonic renal stem cells  by Abraham, Jinu & Keller, Charles
ava i l ab l e a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ loca te / sc r
Stem Cell Research (2010) 5, 1–3EDITORIAL
Renal Stem Cell Biology Starts to Take Spherical Shape
Commentary on: Lusis et al., Isolation of clonogenic, long-term self
renewing embryonic renal stem cellsJinu Abraham, Charles Keller⁎Pediatric Cancer Biology Program, Pape' Family Pediatric Research Institute, Department of Pediatrics, Oregon Health &
Science University, 3181 S.W. Sam Jackson Park Road, Mail Code: L321, Portland, OR 97239-3098, USAAbstract The nephron is the fundamental unit of renal function, yet the ability of the kidney to regenerate nephrons after
birth is limited. Due to the medical and financial impact of chronic and end stage renal disease, an improved understanding of
nephron formation is necessary if regenerative or cell therapy are to be a feasible alternative to dialysis or renal transplant. In
the study presented by Lusis et al., the presence of metanephric mesenchymal stem cells is definitively demonstrated.
However, these “Nephrospheres” have characteristics of mesenchymal stem cells and substantially lack the ability to undergo
an epithelial-to-mesenchyme transition or to form epithelial elements otherwise necessary for building the constituent cells of
the nephron. Nevertheless, this newly isolated cell population opens many opportunities to investigate the consequences of
normal and aberrant nephrogenesis, including Wilm's tumor.
© 2010 Published by Elsevier B.V.Congenital and acquired diseases of the kidney are an
increasingly important medical and financial issue in health
care. For patients with chronic kidney disease in the USA,
Medicare expenditures in 2006 exceeded $49 billion, an
increase of nearly 5 fold from 1993 (U.S.R.D. System, 2008).
From a (patho)physiological point of view, the primary unit
of function (or dysfunction) of the kidney is the nephron,
which regulates pH, electrolyte and fluid balance, blood
pressure, as well as performing its important role in
filtration. Renal dysfunction can arise acutely or gradually
from defects in embryonic and fetal patterning (Schedl,
2007), or may develop insidiously from acquired causes such
as diabetes mellitus, which is reaching epidemic proportions
in younger and younger populations (Atkins and Zimmet,
2010). While preventive measures are the most practical, a
clear and present need exists to slow or reverse the
progression towards end stage renal disease for at risk⁎ Corresponding author. Fax: +1 503 418 5044.
E-mail address: keller@ohsu.edu (C. Keller).
1873-5061/$ – see front matter © 2010 Published by Elsevier B.V.
doi:10.1016/j.scr.2010.05.002patients. Dialysis and renal transplant have made survival
possible for patients with renal failure, but a regenerative or
stem cell therapy remains elusive (Hopkins et al., 2009).
The study presented by Lusis et al. addresses this
interesting and important area of renal stem cell biology.
Although previous studies have demonstrated the presence
of stem/progenitor-like cell populations in adult kidney
(summarized in the author's 2009 review (Hopkins et al.,
2009)), these investigations have not yet shown the stemness
of these cell populations to the extent presented in the study
of prenatal renal cells presented by Lusis and colleagues. In
their current study, the authors have successfully adapted a
hybrid of approaches used in generating neural and non-
neural stem cells to isolate and study stem-like cells from
dissociated embryonic kidneys. The authors term these
embryonic renal stem cells, “Nephrospheres.” In a series of
in vitro and in vivo experiments, the authors demonstrate
the multi-potency of the cells derived from Nephrospheres
(Fig. 1). Conversely, by their methods for isolating embry-
onic Nephrospheres, the authors could not isolate stem cells
Figure 1 Normal and Abnormal Derivatives of Metanephric Mesenchyme during Embryogenesis. Metanephric mesenchyme (MM)
induces ureteric bud (UB) ingrowth from the mesonephric duct, the future collecting system. MM at the interface with the UB becomes
the cap mesenchyme (CM). A complex series of paracrine actions occur between CM and the UB (including but not limited to GDNF/Ret
and Wnt11 signaling, reviewed in (Schedl, 2007)), which are also influenced by the secretion of surrounding stromal cells. CM then
gives rise to renal vesicles, which eventually become the constituent cells of renal tubules (nephrons), with the exception of collecting
ducts. Abnormally formed CM or MM are believed to become nephrogenic rests and/or Wilm's tumor. Experimentally-derived
“Nephrospheres” have properties of stem cells, including self-renewal. However, under conditions tested by Lusis et al.,
nephrospheres rarely give rise to epithelial cell progeny in vitro or in vivo; instead, Nephrospheres have multipotentiality comparable
to mesenchymal stem cells (MSCs).
1Li et al. (2002); Pode-Shakked et at. (2008); Maiti et al. (2000); Camassei et al. (2003); Ma et al. (2001); Murphy et al. (2009); Pajusola
et al. (1992) and Wang et al. (1992).
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3Editorialfrom adult kidney. The procedures and phenotypic charac-
terization for Nephrosphere culture are an important step
forward in understanding the formation (and possibly
regeneration) of the nephron, and will likely aid other
researchers in other studies that may also eventually identify
and characterize resident renal stem cells postnatally.
However, despite the tenacity of Lusis and colleagues,
several questions remain.
Most puzzling is that nephron formation could not be
induced from Nephrospheres, which the authors convincingly
show to have properties of metanephric mesenchyme
(MM). In the late embryo and developing fetus, nearly all
cells of the nephron except the collecting duct are
derived from MM that have undergone a mesenchymal-to-
epithelial transition (the collecting duct is derived from
the mesonephric duct) (Fig. 1). Instead, Nephrospheres
under their experimental conditions appear to be “locked
in” to mesenchymal stem cell-like phenotype, possibly
attributable to ongoing Six2 expression (Self et al., 2006).
This result may not be entirely unexpected, since
formation of the kidney relies upon complex time
sequence of paracrine interactions between not only the
MM and ureteric bud (UB) of the mesonephric duct, but
also upon the paracrine influences of stromal cells
(Batourina et al., 2001). In their study the authors
initiated important experiments to define that Nephro-
spheres have properties both similar to and more
primitive than cap mesenchyme, which is the MM
derivative destined to undergo a mesenchymal-to-epithe-
lial transition; however, ongoing characterization of the
Nephrosphere population in terms of genetic lineage(s) is
likely still needed, as will be reconstitution studies that
interrogate the temporal and spatial requirements for the
mesenchymal-to-epithelial transition and nephron induc-
tion. Importantly, however, the conditions with which to
perform such studies are now known.
An intriguing ask of these studies was the phenotypic
similarity between MM-derived Nephrospheres and Wilm's
tumor cancer cells. Arrested or mispatterned metanephric
mesenchyme is believed to give rise to nephrogenic rests
and/or Wilm's tumor (Schedl, 2007), and the similarity
between Wilm's tumor and metanephric mesenchyme has
been previously noted (Li et al., 2002). Molecular features in
common between Nephrospheres and Wilm's tumor xeno-
grafts include expression of Cadherin 11, CD44 and c-Kit,
although differences include the lack of expression of CD34
in mouse Nephrospheres despite CD34 being found in human
Wilm's tumor (Pode-Shakked et al., 2008). Other markers
such as Ncam, Fzd7 and B-catenin targets (Maiti et al., 2000)
remain to be examined (Fig. 1).
All questions not withstanding, for the field of pediatric
oncology, developmental biology and regenerative medicine
alike, this new approach to isolating embryonically derived
renal stem cells represents a unique and important tool to
investigate the consequences of normal and aberrant
nephrogenesis.Disclosures
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